×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中南大学 [21]
内容类型
期刊论文 [21]
发表日期
2019 [1]
2018 [3]
2017 [2]
2016 [3]
2015 [1]
2014 [7]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共21条,第1-10条
帮助
限定条件
专题:中南大学
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Frequency, clinical features and differential response to therapy of concurrent ALK/EGFR alterations in Chinese lung cancer patients
期刊论文
Drug Design, Development and Therapy, 2019, 卷号: 13, 页码: 1809-1817
作者:
Liu, Jixian
;
Mu, Zhimin
;
Liu, Li
;
Li, Kang
;
Jiang, Richeng
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2019/12/03
ALK rearrangement
EGFR alteration
EML4-ALK
Nonsmall cell lung cancer
Tyrosine kinase inhibitor
Mitogen-activated protein kinase signaling pathway in oral cancer (Review)
期刊论文
Oncology letters, 2018, 卷号: 15, 期号: 2, 页码: 1379-1388
作者:
Peng, Qian
;
Deng, Zhiyuan
;
Pan, Hao
;
Gu, Liqun
;
Liu, Ousheng
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2019/12/03
inhibitor
kinase
mitogen-activated protein kinase signaling pathway
oral cancer
oral squamous cell carcinoma
therapeutic targets
treatment
Broad targeting of triptolide to resistance and sensitization for cancer therapy
期刊论文
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, 卷号: 104, 页码: 771-780
作者:
Hou, Zhen-yan
;
Tong, Xiao-pei
;
Peng, Yong-bo
;
Zhang, Bi-Kui*
;
Yan, Miao*
收藏
  |  
浏览/下载:50/0
  |  
提交时间:2019/12/03
ABC
ATP-binding cassette
AKT
V-Akt murine thymoma viral oncogene homolog
ALDH1
aldehyde dehydrogenase 1
AR
androgen receptor
Bad
Bcl-2-associated death promoter
Bak
Bcl-2 homologous antagonist killer
Bax
Bcl-2-associated X protein
Bcl-2
B-cell lymphoma
Bcl-xL
Bcl-extra large
Bcl-xs
Bcl-extra short
BCRP
breast cancer resistance protein
Bid
BH3 interacting domain death agonist
Bik
Bcl-2-interacting killer
BNIP3
Bcl2/adenovirus E1B 19 kDa protein-interacting protein 3
CAF
cancer-associated fibroblast
CAIX
carbonic anhydrase IX
cFLIP
cellular FLICE (FADD-like IL-1β-converting enzyme)-inhibitory protein
ChIP
chromatin immunoprecipitation
CI
Combination Index
cIAP1/2
cellular IAP1/2
CML
chronic myelogenous leukemia
CSC
cancer stem cell
DISC
death-inducing signaling complex
DR
death receptor
DRI
Dose Reduction Index
ECM
extracellular matrix
EMT
epithelial-mesenchymal transition
EpCAM
epithelial cell adhesion molecule
GLUT
glucose transporter
GSK3β
glycogen synthase kinase-3β
HIF-1
hypoxia inducible factor-1
HSF1
heat shock factor 1
HSP
heat shock protein
IAP
inhibitor of apoptosis protein
JNK
c-JUN N-terminal kinase
MAPK
mitogen-activated protein kinase
Mcl-1
myeloid leukemia cell differentiation protein
MDM2
murine double minute 2
MDR
multidrug resistance
MKP
MAPK phosphatase
MRP1
multidrug resistance protein 1
NF-κB
nuclear factor-kappaB
pAkt
phosphor-Akt
PARP
poly ADP-ribose polymerase
P-gp
P-glycoprotein
PI3K-PTEN
phosphatidylinositol 3-kinase-phosphatase and tensin homolog
PKC
phosphorylated at Ser9 by protein kinase C
pp2A
protein phosphatase 2A
REST
repressor element-1 silencing transcription factor
SAR
structure-activity relationship
TAM
tumor-associated macrophage
TFIIH
transcription factor IIH
TKI
tyrosine kinase inhibitor
TM
tumor-microenvironment
TRAIL/Apo-2L
TNF-related apoptosis-inducing ligand
tRXRα
the N-terminal truncated form of the nuclear retinoid X receptor-α
TWHF
Tripterygium wilfordii Hook F
VEGF
vascular endothelial growth factor
XIAP
X-linked IAP
XPB
xerodermapigmentosum group B protein
Triptolide
Antineoplastic
Resistance
Sensitization
Mechanism
Anlotinib as a third-line therapy in patients with refractory advanced non-small-cell lung cancer: a multicentre, randomised phase II trial (ALTER0302)
期刊论文
British Journal of Cancer, 2018, 卷号: 118, 期号: 5, 页码: 654-661
作者:
Han, Baohui*
;
Li, Kai
;
Zhao, Yizhuo
;
Li, Baolan
;
Cheng, Ying
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2019/12/03
non-small-cell lung cancer
multitarget
tyrosine kinase inhibitor
anlotinib
third line
MicroRNA-93 promotes cell proliferation by directly targeting P21 in osteosarcoma cells
期刊论文
Experimental and Therapeutic Medicine, 2017, 卷号: 13, 期号: 5, 页码: 2003-2011
作者:
He, Yu
;
Yu, Bo*
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/03
P21
cell cycle
cell proliferation
cyclin-dependent kinase inhibitor 1A
microRNA
osteosarcoma
A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506)
期刊论文
BMC Cancer, 2017, 卷号: 17, 期号: 1, 页码: 462
作者:
Zhou, Qing
;
Song, Yong
;
Zhang, Xin
;
Chen, Gong-Yan
;
Zhong, Dian-Sheng
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/03
Chemotherapy
China
Epidermal growth factor receptor
First-line anticancer treatment
Non-small cell lung cancer
Tyrosine kinase inhibitor
Chromatin remodeling factor LSH affects fumarate hydratase as a cancer driver
期刊论文
Chinese Journal of Cancer, 2016, 卷号: 35, 期号: 1, 页码: 491-494
作者:
Liu, Shuang
;
Tao, Yong-Guang*
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2019/12/03
Lymphocyte-specific helicase (LSH)
Epithelial-mesenchymal transition (EMT)
E-Cadherin
ZO-1
Vimentin
Tricarboxylic acid cycle intermediates
Inhibitor of nuclear factor kappa-B kinase alpha (IKKα)
G9a
Protein inhibitor of activated STAT x alpha depresses cyclin D and cyclin D kinase, and contributes to the inhibition of osteosarcoma cell progression
期刊论文
Molecular Medicine Reports, 2016, 卷号: 13, 期号: 2, 页码: 1645-1652
作者:
Wang, Junjie
;
Ni, Jiangdong*
;
Yi, Shuai
;
Song, Deye
;
Ding, Muliang
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/03
protein inhibitor of activated STAT x alpha
osteosarcoma
cyclin D
cyclin D kinase
sumoylation
A single electrochemical biosensor for detecting the activity and inhibition of both protein kinase and alkaline phosphatase based on phosphate ions induced deposition of redox precipitates
期刊论文
Biosensors and Bioelectronics, 2016, 卷号: 85, 页码: 220-225
作者:
Shen, Congcong
;
Li, Xiangzhi
;
Rasooly, Avraham
;
Guo, Linyan
;
Zhang, Kaina
收藏
  |  
浏览/下载:1/0
  |  
提交时间:2019/12/03
Protein kinase
Alkaline phosphatase
Electrochemical
Biosensor
Inhibitor
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
期刊论文
Annals of Oncology, 2015, 卷号: 26, 期号: 9, 页码: 1877-1883
作者:
Zhou, C.*
;
Wu, Y. L.
;
Chen, G.
;
Feng, J.
;
Liu, X. -Q.
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/03
chemotherapy regimen
epidermal growth factor receptors
exons
kinase inhibitors
mutation
phase 3 clinical trials
protein-tyrosine kinase inhibitor
tyrosine
©版权所有 ©2017 CSpace - Powered by
CSpace